No Data
No Data
Express News | Watching AbCellera Biologics; Shares See Volume To The Upside, Traders Circulate Ray Blancos Catalyst Trader Action Alert To Buy The Stock Up To $4
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Individual Investors Who Own 34% Along With Institutions Invested in AbCellera Biologics Inc. (NASDAQ:ABCL) Saw Increase in Their Holdings Value Last Week
AbCellera to Present at Upcoming Investor Conferences in December and January
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating